ALERT!

This site is not optimized for Internet Explorer 8 (or older).

Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.

Journal and News Scan

Source: Journal of Clinical Oncology
Author(s): Rodney J. Landreneau, Daniel P. Normolle, Neil A. Christie, Omar Awais, Joseph J. Wizorek, Ghulam Abbas, Arjun Pennathur, Manisha Shende, Benny Weksler, James D. Luketich and Matthew J. Schuchert

This single institution retrospective study compared outcomes for lobectomy and segmentectomy using propensity score matching.  For 312 pts in each group, there was no difference in logoregional or overall recurrence rates.  Operative mortality rates were similar for segmentectomy and lobectomy (1.2% vs 2.5%).  5-year surival rates were also similar (54% vs 60%). 

Source: Journal of Clinical Oncology
Author(s): Hiran C. Fernando, Rodney J. Landreneau, Sumithra J. Mandrekar, Francis C. Nichols, Shauna L. Hillman, Dwight E. Heron, Bryan F. Meyers, Thomas A. DiPetrillo, David R. Jones, Sandra L. Starnes, Angelina D. Tan, Benedict D.T. Daly and Joe B. Putnam Jr

This randomized trial of high risk patients with small clinial stage I cancers randomized pts to sublobar resection with or without adjuvant brachytherapy.  The median follow-up for 222 pts was 4.4 years.  3 year survival was identical (71%) between the groups.  There was no difference in time to local recurrence.  Brachytherapy did not significantly reduce the incidence of local recurrence, even in patients with close or involved margins. 

Source: Journal of Clinical Oncology
Author(s): Christophe Mariette, Laetitia Dahan, Françoise Mornex, Emilie Maillard, Pascal-Alexandre Thomas, Bernard Meunier, Valérie Boige, Denis Pezet, William B. Robb, Valérie Le Brun-Ly, Jean-François Bosset, Jean-Yves Mabrut, Jean-Pierre Triboulet, Laurent Bedenne and Jean-François Seitz

In this randomized trial involving195 pts from 30 centers, pts underwent chemoradiotherapy followed by surgery or surgery alone for stage I or II esophageal cancer.  The median follow-up was 94 months.  80% of pts had clinical stage II disease.  R0 resection rate and 3-year survival were similar between the groups.  Induction therapy was associated with an increase in operative mortality (11.1% vs 3.4%, p=0.049). 

Source: European Heart Journal
Author(s): Paradis JM, Fried J, Nazif T, Kirtane A, Harjai K, Khalique O, Grubb K, George I, Hahn R, Williams M, Leon MB, Kodali S.

The incidence of coronary artery disease among patients with severe aortic stenosis and candidates for TAVI ranges from 40 to 75%. In the absence of randomized trials, the management of these patients remains to be established. In this paper, the authors offer a good overview of the subject and propose an algorithm for treatment.

Source: Thoracic and Cardiovascular Surgeon
Author(s): Charles Yankah, Francis Fynn-Thompson, Manuel Antunes, Frank Edwin, Christine Yuko-Jowi, Shanthi Mendis, Habib Thameur, Andreas Urban, Ralph Bolman III

This article looks at the availability of cardiac surgery in africa using a survey to calculate the availability of surgeons around this continent and also looks at the models of care employed. 

 

 

Source: The Indian Express
Author(s): Express News Service

A great use for google glasses is demonstrated here. The glasses can be used to film the operative field and communicate with others online in real time. 

Thus real time expert opinions from around the world would potentially be possible with their use. They are used here for the first time.

Source: World Journal for Pediatric and Congenital Heart Surgery
Author(s): William I. Douglas, Unnati Doshi

 

Two-patch, single-patch, and modified single-patch repairs are accepted techniques for repair of complete atrioventricular (AV) canal defects. We propose a novel, alternative technique: the central patch technique.

The central patch technique is applicable to all forms of complete AV canal defect. Subjectively, it offers technical advantages compared to standard techniques and may result in a shorter learning curve for junior congenital heart surgeons. Results are preliminary but are consistent with standard techniques.

 

 

Source: Multimedia Manual of Cardiothoracic Surgery
Author(s): Alan D.L. Sihoe*, Michael K.Y. Hsin and Peter S.Y. Yu

this is a video and article decribing the technique for bullectomy and pleural abrasion using the original drain as a port and 2 3mm ports.

 

Source: New England Journal of Medicine
Author(s): Tommaso Sanna, Hans-Christoph Diener, Rod S. Passman, Vincenzo Di Lazzaro, Richard A. Bernstein, Carlos A. Morillo, Marilyn Mollman Rymer, Vincent Thijs, Tyson Rogers, Frank Beckers, Kate Lindborg, and Johannes Brachmann, for the CRYSTAL AF Investigators

The cause of ischemic stroke remains elusive in up to 20-40% of cases.  In patients with cryptogenic stroke, 8.9% of patients with long term monitoring using an insertable cardiac monitor were found to an episode of atrial fibrillation, which may have implications in therapy.

Source: Heart
Author(s): Abdel-Wahab M, Zahn R, Gerckens U, Linke A, Sievert H, Schäfer U, Kahlert P, Hambrecht R, Sack S, Hoffmann E, Senges J, Schneider S, Richardt G; on behalf of the German TAVI Registry Investigators

In this study the authors use data from 1432 patients included in the German TAVI registry to identify variables which predict poor outcome in patients left with more than mild aortic regurgitation (AR) following TAVI.  The Medtronic Core Valve prosthesis had been used in the great majority of the procedures. 1-year follow up data was available in 92% of the patients. Of these patients, 201 (15.2%) were found to have significant AR. Using Cox regression analysis, only more than mild pre-existing mitral regurgitation and pulmonary hypertension were identified as independent predictors of 1-year mortality .

Pages